ACHE Antibody
- Known as:
- ACHE Antibody
- Catalog number:
- AF1017a
- Product Quantity:
- 0.1mg
- Category:
- -
- Supplier:
- Abgen
- Gene target:
- ACHE Antibody
Related genes to: ACHE Antibody
- Gene:
- ACHE NIH gene
- Name:
- acetylcholinesterase (Cartwright blood group)
- Previous symbol:
- YT
- Synonyms:
- -
- Chromosome:
- 7q22.1
- Locus Type:
- gene with protein product
- Date approved:
- 1989-06-02
- Date modifiied:
- 2019-04-23
Related products to: ACHE Antibody
Related articles to: ACHE Antibody
- We present a 59-year-old man who developed delayed-onset electric shock-like sensations triggered by neck flexion approximately 3-4 weeks after a workplace fall. Immediately after the fall, he experienced a brief episode of transient global sensory loss that resolved within minutes, followed by headache and posterior neck pain. Approximately 10 minutes later, he developed bilateral upper extremity paresthesias in the C6 dermatomal distribution that gradually resolved over several hours. Several weeks later, he developed reproducible electric shock-like sensations radiating from the neck throughout the body with neck flexion, consistent with Lhermitte sign. Neurologic examination revealed no motor or sensory deficits. MRI of the brain was unremarkable, and serial MRI studies of the cervical and thoracic spine showed no intramedullary abnormalities. This case demonstrates a structured clinical reasoning approach to post-traumatic sensory phenomena. - Source: PubMed
Publication date: 2026/09/11
Jafari Tadi MehrdadAggarwal AishwaryaAkinci YaseminRagati Haghi HediehNoor Emad - Functional alignment (FA) has emerged as an alternative to mechanical alignment (MA) in total knee arthroplasty (TKA), supported by robotic assistance to enhance precision and soft‑tissue preservation. Evidence comparing FA performed with robotic assistance to conventional MA‑TKA across mid‑term patient‑reported outcomes measures (PROMs) remains limited. This randomised controlled trial evaluated differences in recovery trajectories and 2‑year knee‑specific outcomes between FA‑RATKA and MA‑CTKA. - Source: PubMed
Publication date: 2026/09/11
Coenen RemcoPeeters ArneBollars PeterNathwani DineshAlbelooshi AliEttinger Max TilDeltour ArnaudSchotanus Martijn Gerhardus Maria - BackgroundAutotransfusion devices concentrate white blood cells (WBCs) within the washed product that may lead to undesirable clinical effects when reinfused to the patient. This quality improvement project evaluated the leukocyte removal efficacy of three types of salvaged blood filters in autologous cell salvage.MethodsUsing a prospective observational cohort approach, we evaluated microaggregate, lipid-reducing, and leukocyte-reducing salvaged blood filters in adult patients undergoing surgery with autologous cell salvage. Filters were evaluated one after another, with samples of processed autologous blood collected prior to filtration and again after 30 mL had passed through each type of filter to allow for direct comparison of each filter's effects on WBC concentrations.ResultsSalvaged blood samples were collected from 35 patients. Median pre-filtration WBC count was 9.8 [6.8-13.3] × 10/L, being reduced to 9.3 [6.6-12.6] × 10/L after microaggregate filtration (1.7 [-0.6-4.6]% removal), 0.8 [0.5-2.5] × 10/L after lipid filtration (89.7 [83.3-93.9]% removal), and 0.0 [0.0-0.0] × 10/L after leukocyte filtration (100 [100-100]% removal). The microaggregate filter achieved significantly less WBC reduction than both the leukocyte-reducing filter ( < 0.0001) and lipid-reducing filter ( < 0.0001). There was no significant difference observed between the leukocyte-reducing and lipid-reducing filters ( = 0.3124).ConclusionsLeukocyte- and lipid-reducing filters were effective at reducing WBCs from processed autologous blood by nearly 10-fold, while microaggregate filters were significantly less effective at removing leukocytes. Use of leukocyte- or lipid-reducing filters minimizes the number of activated WBCs reinfused to the patient during autologous cell salvage. - Source: PubMed
Publication date: 2026/09/11
Alm MarkBush NatashaMaznytsya AlisaDooley MaryDell'aiera LauraMcCluskey Stuart AVallelonga Mark - Rheumatic heart disease (RHD) remains a major public health problem in low- and middle-income countries. Long-term benzathine penicillin G (BPG) secondary prophylaxis prevents recurrent acute rheumatic fever (ARF) and progressive valve damage, but maintaining adequate uptake (i.e., ≥80% dose) remains challenging in high-burden settings. We assessed BPG uptake, factors associated with high uptake, and its association with reported recurrent ARF manifestations among people with RHD in Ethiopia. - Source: PubMed
Publication date: 2026/09/11
Birru Eshetie MeleseBirru Zemikael MeleseBelayneh Yaschilal MucheAlemu Muluken AdelaOliver JaneKebede Zemene Tigabu - Hypermobile Ehlers-Danlos Syndrome (hEDS) is a connective tissue disorder with variable symptom presentation across multiple organ systems and significant morbidity. Little is known about hEDS etiology and identifying patterns of symptom co-occurrence can reveal previously unidentified relationships between phenotypes and inform studies of underlying disease pathophysiology for symptoms that may share functional biological pathways. In this exploratory analysis, we specifically assessed the distribution of symptoms in case and controls to identify clusters of co-occurring symptoms. - Source: PubMed
Publication date: 2026/09/11
Andrews JenniferHarkey ZacheryMathena SarahGalindo MaureenHannon SarrahJesudas RohithLaukaitis Christina M